Deleterious BRCA1/2 mutations in an urban population of Black women

[1]  K. Robison,et al.  Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics Professionals , 2016, American journal of clinical oncology.

[2]  Brigitte Rack,et al.  Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  T. Walsh,et al.  Inherited predisposition to breast cancer among African American women , 2014, Breast Cancer Research and Treatment.

[4]  Nazneen Rahman,et al.  Breast-cancer risk in families with mutations in PALB2. , 2014, The New England journal of medicine.

[5]  Tina Pesaran,et al.  Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients , 2014, Genetics in Medicine.

[6]  S. Vadaparampil,et al.  BRCA sequencing and large rearrangement testing in young Black women with breast cancer , 2013, Journal of Community Genetics.

[7]  P. Marcom,et al.  Prevalence of BRCA Mutations Among Women with Triple-Negative Breast Cancer (TNBC) in a Genetic Counseling Cohort , 2013, Annals of Surgical Oncology.

[8]  I. Jaiyesimi,et al.  Unique genetic characteristics of BRCA mutation carriers in a cohort of Arab American women. , 2013 .

[9]  A. Monteiro,et al.  Early Onset Breast Cancer in a Registry‐based Sample of African‐American Women: BRCA Mutation Prevalence, and Other Personal and System‐level Clinical Characteristics , 2013, The breast journal.

[10]  H. Valdimarsdottir,et al.  Receipt of genetic counseling recommendations among black women at high risk for BRCA mutations. , 2012, Genetic testing and molecular biomarkers.

[11]  Beth A. Glenn,et al.  Barriers to genetic testing for breast cancer risk among ethnic minority women: an exploratory study. , 2012, Ethnicity & disease.

[12]  M. Putt,et al.  The Influence of Health Care Policies and Health Care System Distrust on Willingness to Undergo Genetic Testing , 2012, Medical care.

[13]  E. Rosenthal,et al.  Clinical significance of large rearrangements in BRCA1 and BRCA2 , 2012, Cancer.

[14]  C. Isaacs,et al.  Long‐term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance , 2012, Cancer.

[15]  H. Valdimarsdottir,et al.  Ethnic, Racial and Cultural Identity and Perceived Benefits and Barriers Related to Genetic Testing for Breast Cancer among At-Risk Women of African Descent in New York City , 2011, Public Health Genomics.

[16]  S. Gruber,et al.  Genetic/familial high-risk assessment: breast and ovarian. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

[17]  Christine B Ambrosone,et al.  Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors , 2009, Breast Cancer Research.

[18]  B. Ward,et al.  BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast‐ovarian cancer , 2009, Cancer.

[19]  H. Nevanlinna,et al.  The Breast Cancer Susceptibility Mutation PALB2 1592delT Is Associated with an Aggressive Tumor Phenotype , 2009, Clinical Cancer Research.

[20]  Stephanie A Cohen,et al.  The prevalence of BRCA1 mutations among young women with triple-negative breast cancer , 2009, BMC Cancer.

[21]  Christopher I Amos,et al.  Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  O. Olopade,et al.  Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers , 2008, Genetics in Medicine.

[23]  Alice S Whittemore,et al.  Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. , 2007, JAMA.

[24]  R. Cress,et al.  Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype , 2007, Cancer.

[25]  Giske Ursin,et al.  Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. , 2006, Cancer research.

[26]  Ken R. Smith,et al.  Risk Reduction Behaviors and Provider Communication Following Genetic Counseling and BRCA1 Mutation Testing in an African American Kindred , 2006, Journal of Genetic Counseling.

[27]  O. Olopade,et al.  “Why take it if you don’t have anything?” breast cancer risk perceptions and prevention choices at a public hospital , 2006, Journal of General Internal Medicine.

[28]  S. Domchek,et al.  Recruiting African American women to participate in hereditary breast cancer research. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  L. Esserman,et al.  Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. , 2005, JAMA.

[30]  B. Haffty,et al.  Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women , 2005, Journal of Medical Genetics.

[31]  Marilie D. Gammon,et al.  Breast cancers among very young premenopausal women (United States) , 2003, Cancer Causes & Control.

[32]  P. Laurent-Puig,et al.  BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group. , 1997, American journal of human genetics.

[33]  Karla Bowles,et al.  Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next‐generation sequencing with a 25‐gene panel , 2015, Cancer.

[34]  Hodgkin Lymphoma.  NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines , 2014 .

[35]  C. Isaacs,et al.  BRCA1/2 mutations and triple negative breast cancers. , 2010, Breast disease.

[36]  James P Evans,et al.  Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.